Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
Advances in Next Generation Sequencing (NGS) are driving improvements in detection, treatment and routine monitoring of cancer. Faster and more accurate assays will ultimately lead to better outcomes for patients.
Hear from key opinion leaders in the cancer research and clinical oncology field, and learn how they overcome their research hurdles using Twist’s robust and effective NGS target enrichment solutions.